Skip to content
Search

Latest Stories

Low-fat vegan diet reduces insulin needs and lowers heart disease risk in diabetes patients

Participants on the low-fat vegan diet saw a 28 per cent drop in insulin needs and a remarkable 127 per cent boost in insulin sensitivity.

Low-fat vegan diet reduces insulin needs and lowers heart disease risk in diabetes patients

A recent study has revealed promising results regarding the efficacy of a low-fat vegan diet in managing Type 1 diabetes and reducing the risk of heart disease.

Conducted by researchers at the Physicians Committee for Responsible Medicine in the US and published in the Clinical Diabetes journal, the study sheds light on the potential benefits of adopting a plant-based diet for individuals with Type 1 diabetes.


Type 1 diabetes is an autoimmune condition characterised by the body's immune system attacking the pancreas, leading to impaired insulin production and blood sugar regulation.

Consequently, patients often require regular insulin injections to manage their condition. However, the study suggests that dietary interventions, particularly a low-fat vegan diet, may significantly reduce insulin needs and improve overall health outcomes.

low-fat-vegan-diet Hana Kahleova, MD, PhD (Photo credit: www.pcrm.org)

Lead author Hana Kahleova, Director of Clinical Research at the Physicians Committee for Responsible Medicine, highlights the groundbreaking nature of the research, emphasising its potential to alleviate concerns surrounding the cost of insulin and enhance the management of blood sugar levels in Type 1 diabetes patients.

The study involved 58 adults with Type 1 diabetes who were randomly assigned to either a low-fat vegan group or a portion-controlled group.

Over 12 weeks, participants following the low-fat vegan diet experienced a 28 per cent reduction in insulin requirements and a remarkable 127 per cent improvement in insulin sensitivity.

These effects were attributed to changes in body weight, with participants on the vegan diet experiencing an average weight loss of five kilograms.

Notably, the study found that increased carbohydrate and fibre intake associated with the vegan diet contributed to improved insulin sensitivity and reduced insulin requirements. These findings align with previous research linking lower fat and protein intake to better outcomes in Type 1 diabetes management.

Furthermore, the study explored the cardiovascular benefits of the low-fat vegan diet, as individuals with Type 1 diabetes are at higher risk of heart disease. The researchers observed significant reductions in total cholesterol and LDL cholesterol levels among participants in the vegan group, translating to a decreased risk of cardiovascular events such as heart attack and stroke.

While acknowledging the need for larger trials to validate these findings, the study shows the potential of a low-fat vegan diet as a holistic approach to managing Type 1 diabetes and reducing associated cardiovascular risks.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less